Antios Therapeutics Company

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

Funding Status: Early Stage Venture
Industry: Biopharma, Biotechnology, Therapeutics
Technology: Cancer
Headquarters: Atlanta, Georgia, United States
Total Funding: 125399999
Last Funding Date: 2021
Last Funding Type: Series B
Investor Type: Early Stage Venture
Employee Number: 11-50
Investors Number: 16
Founded Date: 2018